This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Au H-J, Robert N, Eiermann W, Pienkowski T, Crown J, Martin M, Pawlicki M, Chan A, Bee V, Slamon D.BCIRG 006: quality of life of patients treated with docetaxel and trastuzumab-based regimens in node positive and high risk node negative HER2 positive early breast cancer. Breast Cancer Research and Treatment 106 (Suppl. 1): 147 (plus poster) abstr. 3063, Dec 2007
Rights and permissions
About this article
Cite this article
Docetaxel and trastuzumab-based therapies all good news for QOL. Pharmacoecon. Outcomes News 544, 10 (2008). https://doi.org/10.2165/00151234-200805440-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805440-00024